Company intelligence / Profile preview

Irbit Chemical and Pharmaceutical Plant

Irbit, Sverdlovsk, Russiapitchbook.com ↗

Ownership: Private
Employees: ~870
Development stage: Commercial

Overview

Irbit Chemical and Pharmaceutical Plant is one of Russia’s largest manufacturers of finished medicines and active pharmaceutical ingredients. It operates a full-cycle GMP-certified facility with modern production lines for tablets, capsules, effervescent forms, and chemical synthesis. The plant supplies more than 80 products to the Russian Federation and CIS countries. Notable products include antiviral drugs such as umifenovir ("Nobazit") and nitroxoline-based antibiotics. Over 30% of its portfolio is included in Russia’s Vital & Essential Drugs List.

Modalities: Small molecule
Industry: Biotech

Drug pipeline

1 asset

menthyl valerate

Unknown

Beyond the preview

Go deeper on Irbit Chemical and Pharmaceutical Plant.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Irbit Chemical and Pharmaceutical Plant.

Explore the full profile